Assenagon Asset Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-93,720
Closed -$270K 1328
2023
Q1
$270K Sell
93,720
-100,114
-52% -$292K ﹤0.01% 1318
2022
Q4
$454K Buy
193,834
+118,469
+157% +$362K ﹤0.01% 1190
2022
Q3
$338K Sell
75,365
-7,198
-9% -$51.5K ﹤0.01% 1176
2022
Q2
$484K Buy
+82,563
New +$424K ﹤0.01% 1232

Other funds holding APYX

Assenagon Asset Management's APYX Position: Q2 2023 in Review

Assenagon Asset Management sold out of Apyx Medical (APYX) in Q2 2023, closing a stake of 93,720 shares — an estimated $270K sold.

Assenagon Asset Management first reported a position in APYX in Q2 2022 and held it in 4 quarters. The position peaked at $484K in Q2 2022. 56 funds tracked by Wall St. Rank hold APYX as of Q2 2023.

  • Assenagon Asset Management reported no remaining Apyx Medical position as of Q2 2023 after selling out during the quarter.
  • Assenagon Asset Management sold 93,720 Apyx Medical shares in Q2 2023, an estimated $270K.
  • Assenagon Asset Management first reported a position in Apyx Medical in Q2 2022 and held it in 4 quarters.
  • Assenagon Asset Management's Apyx Medical position peaked at $484K in Q2 2022.
  • 56 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2023.

Based on Assenagon Asset Management's 13F filing for Q2 2023, filed 25 Jul 2023.